Advertisement

Reappraisal of Transurethral Resection in Classic Interstitial Cystitis

  • Magnus FallEmail author
Chapter

Abstract

The idea of removing Hunner lesions to improve symptoms is not new. Guy Hunner himself found that resection of lesions was one means to obtain symptom remission, although mostly short-lived so he gave up this kind of treatment. TUR was on trial more recently [1, 2] but this kind of surgery was not accepted when we started our first series. Initially, when applying TUR our goals were twofold: to obtain sufficient tissue to permit a reliable and sufficiently detailed histopathological diagnosis, and also to establish whether careful resection of lesions actually could help patients. At this stage there was some skepticism, with questions like: if you have an ulcer and by an operation create an even bigger ulcer, how is it possible that such a measure would make any improvement? There are reasonable explanations, though [3, 4]: peripheral denervation with removal of inflamed nerve endings, reduction of aggregates of potent inflammatory mediators and elimination of epithelial mast cell recruiting factors as well as epithelial and subepithelial mast cells might cause disease remission. In this context it is worth noting that perineural localization of inflammatory cells is a very typical feature in classic interstitial cystitis [5]. At the initial stage there was also much uncertainty about what Hunner lesions really look like [6] and certainly about their prevalence. Prevalence was thought to be in the range of 5–10% of subjects with bladder pain while in our series it is around 50% [7, 8]. Recent reports indicate that the use of cystoscopy and bladder distension as a routine in BPS/IC—or lack of such routine—is decisive for the number of patients with Hunner lesion you detect or miss. In centers where the traditional way of diagnostics was not abandoned prevalence similar to ours has been reported. Fortunately, the role of cystoscopy is now increasingly appreciated worldwide [9, 10].

References

  1. 1.
    Kerr WJ. Interstitial cystitis: treatment by transurethral resection. J Urol. 1971;105(5):664–6.CrossRefPubMedGoogle Scholar
  2. 2.
    Greenberg E, Barnes R, Stewart S, Furnish T. Transurethral resection of Hunner’s ulcers. J Urol. 1974;111:764–6.CrossRefPubMedGoogle Scholar
  3. 3.
    Fall M. Conservative management of chronic interstitial cystitis: transcutaneous electrical nerve stimulation and transurethral resection. J Urol. 1985;133:774–8.CrossRefPubMedGoogle Scholar
  4. 4.
    Peeker R, Aldenborg F, Fall M. Complete transurethral resection of ulcers in classic interstitial cystitis. Int Urogynecol J. 2000;11:290–5.CrossRefGoogle Scholar
  5. 5.
    Fall M, Johansson SL, Vahlne A. A clinicopathological and virological study of interstitial cystitis. J Urol. 1985;133(5):771–3.CrossRefPubMedGoogle Scholar
  6. 6.
    Gillenwater JY, Wein AJ. Summary of the National Institute of Arthritis, Diabetes, Digestive and Kidney Diseases Workshop on Interstitial Cystitis, National Institutes of Health, Bethesda, Maryland, August 28-29, 1987. J Urol. 1988;140(1):203–6.CrossRefPubMedGoogle Scholar
  7. 7.
    Peeker R, Fall M. Towards a precise definition of interstitial cystitis: further evidence of differences in classic and nonulcer disease. J Urol. 2002;167:2470–2.CrossRefPubMedGoogle Scholar
  8. 8.
    Logadottir Y, Fall M, Kåbjörn-Gustafsson C, Peeker R. Clinical characteristics differ considerably between phenotypes of bladder pain syndrome/interstitial cystitis. Scand J Urol Nephrol. 2012;46(5):365–70.CrossRefPubMedGoogle Scholar
  9. 9.
    Homma Y, Ueda T, Tomoe H, Lin A, Kuo H, Lee M, et al. Clinical guidelines for interstitial cystitis and hypersensitive bladder updated in 2015. Int J Urol. 2016;23(7):542–9. Epub 2016 May 24CrossRefPubMedGoogle Scholar
  10. 10.
    Doiron R, Tolls V, Irvine-Bird K, Kelly K, Nickel J. Clinical phenotyping does not differentiate hunner lesion subtype of interstitial cystitis/bladder pain syndrome: a relook at the role of cystoscopy. J Urol. 2016;196(4):1136–40.CrossRefPubMedGoogle Scholar
  11. 11.
    Chennamsetty A, Khourdaji I, Goike J, Killinger K, Girdler B, Peters K. Electrosurgical management of Hunner ulcers in a referral center’s interstitial cystitis population. Urology. 2015;85(1):74–8. Epub 2014 Nov 5.CrossRefPubMedGoogle Scholar
  12. 12.
    van de Merwe JP, Nordling J, Bouchelouche P, Bouchelouche K, Cervigni M, Daha LK, et al. Diagnostic criteria, classification, and nomenclature for painful bladder syndrome/interstitial cystitis: an ESSIC proposal. Eur Urol. 2008;53(1):60–7.CrossRefPubMedGoogle Scholar
  13. 13.
    Fall M, Johansson SL, Aldenborg F. Chronic interstitial cystitis: a heterogeneous syndrome. J Urol. 1987;137:35–8.CrossRefPubMedGoogle Scholar
  14. 14.
    Logadottir Y, Ehren I, Fall M, Wiklund NP, Peeker R. Intravesical nitric oxide production discriminates between classic and nonulcer interstitial cystitis. J Urol. 2004;171:1148–51.CrossRefPubMedGoogle Scholar
  15. 15.
    Peeker R, Aldenborg F, Dahlström A, Johansson SL, Li J-Y, Fall M. Increased tyrosine hydroxylase immunoreactivity in bladder tissue from patients with classic and nonulcer interstitial cystitis. J Urol. 2000;163:112–5.Google Scholar
  16. 16.
    Peeker R, Fall M, Enerbäck L, Aldenborg F. Recruitment, distribution and phenotypes of mast cells in interstitial cystitis. J Urol. 2000;163:1009–15.CrossRefPubMedGoogle Scholar
  17. 17.
    Nordling J, Anjum F, Bade J, Bouchelouche K, Bouchelouche P, Cervigni M, et al. Primary evaluation of patients suspected of having interstitial cystitis (IC). Eur Urol. 2004;45(5):662–9.CrossRefPubMedGoogle Scholar
  18. 18.
    Engeler D, Baranowski A, Dinis-Oliveira P, Elneil S, Hughes J, Messelink E, et al. The 2013 EAU guidelines on chronic pelvic pain: is management of chronic pelvic pain a habit, a philosophy, or a science? 10 years of development. Eur Urol. 2013;64(3):431–9.CrossRefPubMedGoogle Scholar
  19. 19.
    Fall M, Baranowski A, Elneil S, Engeler D, Hughes J, Messelink E, et al. EAU guidelines on chronic pelvic pain. Eur Urol. 2010;57(1):35–48.CrossRefPubMedGoogle Scholar
  20. 20.
    Fall M, Baranowski AP, Fowler CJ, Lepinard V, Malone-Lee JG, Messelink EJ, et al. EAU guidelines on chronic pelvic pain. Eur Urol. 2004;46(6):681–9.CrossRefPubMedGoogle Scholar
  21. 21.
    Hanno P, Burks D, Clemens J, Dmochowski R, Erickson D, Fitzgerald M, et al. AUA guideline for the diagnosis and treatment of interstitial cystitis/bladder pain syndrome. J Urol. 2011;185(6):2162–70.CrossRefPubMedGoogle Scholar
  22. 22.
    Schulte TL, Reynolds LR. Transurethral intramural injection of hydrocotone hyaluronidase for interstitial cystitis (hunner's ulcers). J Urol. 1956;75:63–5.CrossRefPubMedGoogle Scholar
  23. 23.
    Cox M, Klutke JJ, Klutke GC. Assessment of patient outcomes following submucosal injection of triamcinolone for treatment of Hunners ulcer subtype interstitial cystitis. Can J Urol. 2009;16:4536–40.PubMedGoogle Scholar

Copyright information

© Springer International Publishing AG 2018

Authors and Affiliations

  1. 1.Department of UrologyInstitute of Clinical Sciences, Sahlgrenska Academy at the University of GothenburgGöteborgSweden

Personalised recommendations